高级检索
当前位置: 首页 > 详情页

Circular RNA ciRS-7 Maintains Metastatic Phenotypes as a ceRNA of miR-1299 to Target MMPs

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Res Ctr, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China [2]Hebei Med Univ, Tumor Res Inst, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China [3]Hebei Med Univ, Anim Ctr, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China [4]Hebei Med Univ, Breast Dis Diagnost & Therapeut Ctr, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China [5]Hebei Med Univ, Affiliated Hosp 4, 12 Jiankang St, Shijiazhuang 050017, Hebei, Peoples R China
出处:
ISSN:

摘要:
Circular RNA ciRS-7 has been reported to act as a competing endogenous RNA (ceRNA) of the miRNA miR-7, resulting in reduced miR-7 activity and increased miR-7-targeted transcripts. However, it is unknown if ciRS-7 harbors other miRNAs with regulatory roles in triple-negative breast cancer (TNBC). The present study determined that the expression of ciRS-7 in TNBC clinical specimens and representative cells is significantly higher than other breast cancer subtypes. Functionally, downregulation of ciRS-7 inhibited cell migration and invasion of TNBC cells. Knockdown of ciRS-7 expression also inhibited the liver and lung metastasis of TNBC cells in vivo. Mechanistic studies revealed that ciRS-7 contains 20 miR-1299-binding sites and func-tions as a ceRNA of miR-1299 in TNBC cells. High expression of ciRS-7 maintains the high migration and invasion properties of TNBC cells by acting as a ceRNA of miR-1299 to enhance the expression of matrix metalloproteinases family members (MMP). Implications: Circular RNA ciRS-7 is highly expressed in TNBC tumor specimens and cells, and its downregulation inhibits cell migration and invasion of TNBC cells in vitro and in vivo. In addition, ciRS-7 functions as a ceRNA of miR1299 to enhance the expression of MMPs, which maintains the high migration and invasion properties of TNBC cells. (C) 2018 AACR.

基金:

基金编号: 81001178 16967788D

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2018]版:
大类 | 2 区 医学
小类 | 3 区 细胞生物学 3 区 肿瘤学
最新[2025]版:
大类 | 2 区 医学
小类 | 3 区 细胞生物学 3 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q2 CELL BIOLOGY Q2 ONCOLOGY
最新[2023]版:
Q2 CELL BIOLOGY Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Res Ctr, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China [2]Hebei Med Univ, Tumor Res Inst, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Hebei Med Univ, Res Ctr, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China [2]Hebei Med Univ, Tumor Res Inst, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China [4]Hebei Med Univ, Breast Dis Diagnost & Therapeut Ctr, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China [*1]the Fourth Affiliated Hospital of Hebei Medical University, No. 12 Jiankang Street, Changan District, Shijiazhuang, Hebei 050017, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39767 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号